Ramharter Michael, Schlabe Stefan, Hübner Marc P, Michelitsch Pia, Kurth Florian, Bélard Sabine, Nordmann Tamara, Davi Saskia Dede
Bernhard Nocht Institute for Tropical Medicine & I. Dep. of Medicine University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Centre de Recherche Médicales de Lambaréné, Lambaréné, Gabon.
Infection. 2025 Jun;53(3):851-872. doi: 10.1007/s15010-024-02443-2. Epub 2025 May 21.
Loiasis is a complex filarial infection endemic in Central Africa and parts of West Africa. Loa loa is transmitted by the deer fly Chrysops dimidiata and C. silacea. The clinical manifestation of the disease is highly variable ranging from asymptomatic infection, symptomatic disease, to life-threatening complications. The diagnosis of L. loa infection is challenging due to a significant proportion of occult infections and a lack of reliable point of care tests. While diethylcarbamazine is the gold standard for curative treatment in many non-endemic countries, its use is limited in endemic regions due to its propensity for severe adverse drug reactions that may occasionally lead to life threatening complications. Alternative treatment regimens have specific indications and limitations in the treatment of loiasis. In this guideline, issued by the German Society for Tropical Medicine, Travel Medicine, and Global Health, recommendations for the diagnosis, management, treatment, and prevention of loiasis are provided based on the currently available best evidence, and gaps in our understanding are highlighted.
罗阿丝虫病是一种复杂的丝虫感染病,流行于中非和西非部分地区。罗阿丝虫由斑虻传播,主要媒介为分斑虻和静斑虻。该病临床表现高度多样,从无症状感染、有症状疾病到危及生命的并发症。由于大量隐匿感染以及缺乏可靠的即时检验,罗阿丝虫感染的诊断具有挑战性。虽然在许多非流行国家,乙胺嗪是治疗的金标准,但在流行地区其使用受到限制,因为它容易引发严重药物不良反应,偶尔可能导致危及生命的并发症。替代治疗方案在罗阿丝虫病治疗中有特定的适应症和局限性。在德国热带医学、旅行医学和全球健康协会发布的本指南中,基于目前可得的最佳证据,提供了罗阿丝虫病诊断、管理、治疗和预防的建议,并突出了我们认识上的差距。